Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Selecting Chemotherapy With High-throughput Drug Screen Assay Using Patient Derived Organoids in Patients With Refractory Solid Tumours (SCORE)

NCT04279509 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.

NCT NCT04279509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04279509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Selecting Chemotherapy With High-throughput Drug Screen Assay Using Patient Derived Organoids in Patients With Refractory Solid Tumours (SCORE)
Lead sponsor
National University Hospital, Singapore
Phase
Not applicable
Overall status
Unknown status
Start date
May 29, 2019
Completion date
May 31, 2022
Enrollment
35 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, epithelial ovarian cancer, hnscc, organoids